About Us
Login
Retail Customer Login
Business User Login
Registration
Retail Customer Registration
Business User Registration
0
Shop Products
Ambulatory Equipment
Apparel
Appliances (Durable Goods)
Body Pressure Relief and Positioning
Clinical Laboratory
Diagnostic Instruments and Supplies
Drainage and Suction
Furnishings
Gloves
Housekeeping
Implants
Incontinence
Indicators and Signage
Instruments
IV Therapy
Needles and Syringes
Nurse's Station and Office Supplies
Nutritionals and Feeding Supplies
Orthopedic
Ostomy
other
Personal Hygiene
Pharmaceuticals
Physical Therapy
Respiratory
Services
Sterilization
Textiles
Training and Education
Urological
Utensils
Ventilators
Wound Care
Wound Closure
0
Retail Customer Login
Business User Login
Retail Customer Registration
Business User Registration
Shop Products
Ambulatory Equipment
Apparel
Appliances (Durable Goods)
Body Pressure Relief and Positioning
Clinical Laboratory
Diagnostic Instruments and Supplies
Drainage and Suction
Furnishings
Gloves
Housekeeping
Implants
Incontinence
Indicators and Signage
Instruments
IV Therapy
Needles and Syringes
Nurse's Station and Office Supplies
Nutritionals and Feeding Supplies
Orthopedic
Ostomy
other
Personal Hygiene
Pharmaceuticals
Physical Therapy
Respiratory
Services
Sterilization
Textiles
Training and Education
Urological
Utensils
Ventilators
Wound Care
Wound Closure
$
Go Back
(D(CH2)51,TYR(ME)2,THR4,ORN8,TYR-) 5mg This oxytocin antagonist shows enhanced affinity for rat uterine oxytocin receptors after iodination. (Disulfide bond) CAS: 114056-26-7 C54H79N11O13S2 FW: 1154.42. Synonym: OVTA.
(SAR9,MET(O2)11)-SUBSTANCE P, 1mg This NK-1 receptor agonist exhibits the highest selectivity for NK-1 receptors in various bioassays. It evokes a concentration-dependent increase in mucus secretion and is much more potent than substance P (EC50= 1.7 -10-6M). CAS: 110880-55-2 C64H100N18O15S FW: 1393.68. substance P.
(SAR9,MET(O2)11)-SUBSTANCE P, 5mg This NK-1 receptor agonist exhibits the highest selectivity for NK-1 receptors in various bioassays. It evokes a concentration-dependent increase in mucus secretion and is much more potent than substance P (EC50= 1.7 -10-6M). CAS: 110880-55-2 C64H100N18O15S FW: 1393.68. substance P.
Z-D-PHE-PHE-GLY-OH. 250mg A high level of inhibition of virus replication was obtained with this peptide, which resembles a region of a viral polypeptide. CAS: 75539-79-6 C28H29N3O6 FW: 503.56 . Synonym: Fusion Inhibitory Peptide, FIP, Virus Replication Inhibitory Peptide
Z-D-PHE-PHE-GLY-OH. 1G A high level of inhibition of virus replication was obtained with this peptide, which resembles a region of a viral polypeptide. CAS: 75539-79-6 C28H29N3O6 FW: 503.56 . Synonym: Fusion Inhibitory Peptide, FIP, Virus Replication Inhibitory Peptide
MIRACULIN (1-20). 1mg DSAPNPVLDIDGEKLRTGTN corresponds to the N-terminal sequence of the taste-modifying 191 amino acid-containing protein miraculin produced by the berries of Richadella dulcifica. CAS: 198694-37-0 C88H146N26O34 FW: 2112.28 . miraculin
MIRACULIN (1-20). 5mg DSAPNPVLDIDGEKLRTGTN corresponds to the N-terminal sequence of the taste-modifying 191 amino acid-containing protein miraculin produced by the berries of Richadella dulcifica. CAS: 198694-37-0 C88H146N26O34 FW: 2112.28 . miraculin
MITOGENIC PENTAPEPTIDE. 5mg This lipopeptide represents a potent activator for monocytes/macrophages and B lymphocytes. CAS: 87173-03-3 C67H124N6O14S FW: 1269.82 . Synonym: Pam3Cys-Ser-Ser-Asn-Ala-OH, Pam3CSSNA
REC TNF-A (HUMAN). 10ug This monocyte-macrophage-derived cytokine was first characterized by its in vivo antitumor properties and in vitro cytotoxicity to certain transformed cell lines. TNF-+ also exerts a growth-enhancing effect on various cells and thus is a bifunctional growth regulator like e.g. IFN-+. As a mediator of inflammatory processes, TNF-+ shares many similar biological activities with IL-1. For our monoclonal antibody to rec TNF-+ (human) please see T-1401. CAS: 94948-59-1 FW: . TNF
BACTENECIN. 0.5mg Bactenecin, a cyclic cationic dodecapeptide, was isolated from bovine neutrophil granules. It exhibits a remarkable antibacterial activity in vitro which is comparable to that of the defensins. (Disulfide bond) CAS: 116229-36-8 C63H118N24O13S2 FW: 1483.92 . bactenecin
BACTENECIN. 1mg Bactenecin, a cyclic cationic dodecapeptide, was isolated from bovine neutrophil granules. It exhibits a remarkable antibacterial activity in vitro which is comparable to that of the defensins. (Disulfide bond) CAS: 116229-36-8 C63H118N24O13S2 FW: 1483.92 . bactenecin
BACTENECIN. 5mg Bactenecin, a cyclic cationic dodecapeptide, was isolated from bovine neutrophil granules. It exhibits a remarkable antibacterial activity in vitro which is comparable to that of the defensins. (Disulfide bond) CAS: 116229-36-8 C63H118N24O13S2 FW: 1483.92 . bactenecin
H-GLY-PRO-GLY-OH. 250mg CAS: 2441-63-6 C9H15N3O4 FW: 229.24
REC PTH-RELATED PROTEIN (1-86) (H. 0.5mg pTHrP (1-86) increased bone formation in vitro. FW: . Synonym: rec Hypercalcemia of Malignancy Factor (1-86) (human)
DEFENSIN HNP-1 (HUMAN). 0.5mg (Disulfide bonds between Cys2 and Cys30/Cys4 and Cys19/Cys9 and Cys29) CAS: 136661-76-2 C150H222N44O38S6 FW: 3442.08 . Synonym: Human Neutrophil Peptide-1, HNP-1
DEFENSIN HNP-1 (HUMAN). 1mg (Disulfide bonds between Cys2 and Cys30/Cys4 and Cys19/Cys9 and Cys29) CAS: 136661-76-2 C150H222N44O38S6 FW: 3442.08 . Synonym: Human Neutrophil Peptide-1, HNP-1
H-GLY-PRO-GLY-NH2 -HCL. 1G GPG-NH2 was shown to inhibit the replication of HIV-1 via its metabolite +-hydroxyglycineamide. The tripeptide added to the antiviral effect of both zidovudine and ritonavir. CAS: 141497-12-3 C9H16N4O3 -+ HCl FW: 264.71 . antiviral peptide
A-CGRP (8-37) (HUMAN). 1mg CGRP and calcitonin cross-react with each other at the levels of their distinct receptors. +-CGRP (8-37) has been described as a selective antagonist for CGRP receptors but not for calcitonin receptors. This fragment thus appears to be a valuable tool for receptor characterization studies. CAS: 119911-68-1 C139H230N44O38 FW: 3125.63 . Synonym: Calcitonin Gene-Related Peptide I (8-37) (human), CGRP-I (8-37) (human)
A-CGRP (8-37) (HUMAN). 5mg CGRP and calcitonin cross-react with each other at the levels of their distinct receptors. +-CGRP (8-37) has been described as a selective antagonist for CGRP receptors but not for calcitonin receptors. This fragment thus appears to be a valuable tool for receptor characterization studies. CAS: 119911-68-1 C139H230N44O38 FW: 3125.63 . Synonym: Calcitonin Gene-Related Peptide I (8-37) (human), CGRP-I (8-37) (human)
AC-MURAMYL-ALA-D-GLU(LYS(STEAROYL)-. 1mg The investigation of the adjuvant activity of this muramyl peptide on humoral and cellular immune responses showed that it aug ments the mitogenic responses of splenic lymphocytes to phytohemagglutinin and lipopolysaccharide and the formation of antibodies to sheep erythrocytes in mice. In addition, it potentiated polyclonal B cell activation in vivo and in vitro. CAS: 78113-36-7 C43H78N6O13 FW: 887.13 . Synonym: Ac-muramyl-Ala-D-Isogln-Lys(stearoyl)-OH, MDP-Lys(L 18), Muroctasin, Romurtide
AC-MURAMYL-ALA-D-GLU(LYS(STEAROYL)-. 5mg The investigation of the adjuvant activity of this muramyl peptide on humoral and cellular immune responses showed that it aug ments the mitogenic responses of splenic lymphocytes to phytohemagglutinin and lipopolysaccharide and the formation of antibodies to sheep erythrocytes in mice. In addition, it potentiated polyclonal B cell activation in vivo and in vitro. CAS: 78113-36-7 C43H78N6O13 FW: 887.13 . Synonym: Ac-muramyl-Ala-D-Isogln-Lys(stearoyl)-OH, MDP-Lys(L 18), Muroctasin, Romurtide
VIP ANTAGONIST. 0.5mg This peptide, a hybrid of neurotensin (6-11) and VIP (7-28), is a competitive antagonist of VIP-binding to glial cells. In rats with reduced masculine potential, this molecule markedly inhibits VIP-stimulated sexual behaviour. Furthermore, it has been shown to antagonize VIP receptors on non-small cell lung cancer cells, thereby inhibiting tumor growth in vitro and in vivo. CAS: 125093-93-8 C154H257N49O40S FW: 3467.11 . VIP
VIP ANTAGONIST. 1mg This peptide, a hybrid of neurotensin (6-11) and VIP (7-28), is a competitive antagonist of VIP-binding to glial cells. In rats with reduced masculine potential, this molecule markedly inhibits VIP-stimulated sexual behaviour. Furthermore, it has been shown to antagonize VIP receptors on non-small cell lung cancer cells, thereby inhibiting tumor growth in vitro and in vivo. CAS: 125093-93-8 C154H257N49O40S FW: 3467.11 . VIP
Z-Gly-Gly-Arg-AMC.HCl.
L-Arginine, Hydrochloride 25G. L-Arginine, Hydrochloride, CAS Number: 1119-34-2, Molecular Formula: C6H14N4O2.HCl, Molecular Weight: 210.67, Synonyms: Detoxargin, Levargin, Minophagen A, Arg, R, 2-amino-5-guanedinovaleric acid, (s)-2-amino-5-[(aminoiminom
Thymidine 1G. Thymidine, cell culture reagent, Purity:
99%, CAS Number: 50-89-5, Molecular Formula: C10H14N2O5, Molecular Weight: 242.2, Form: Powder, color: White, Synonyms: Thymine-2-deoxyriboside, Deoxythymidine, DT, DTHYD;1-(2-Deoxy-B-D-ribofuranosyl)-5-methyluracil, size: 1G
Thymidine 5G. Thymidine, cell culture reagent, Purity:
99%, CAS Number: 50-89-5, Molecular Formula: C10H14N2O5, Molecular Weight: 242.2, Form: Powder, color: White, Synonyms: Thymine-2-deoxyriboside, Deoxythymidine, DT, DTHYD;1-(2-Deoxy-B-D-ribofuranosyl)-5-methyluracil, size: 5G
Thymidine 10G. Thymidine, cell culture reagent, Purity:
99%, CAS Number: 50-89-5, Molecular Formula: C10H14N2O5, Molecular Weight: 242.2, Form: Powder, color: White, Synonyms: Thymine-2-deoxyriboside, Deoxythymidine, DT, DTHYD;1-(2-Deoxy-B-D-ribofuranosyl)-5-methyluracil, size: 10G
Thymidine 25G. Thymidine, cell culture reagent, Purity:
99%, CAS Number: 50-89-5, Molecular Formula: C10H14N2O5, Molecular Weight: 242.2, Form: Powder, color: White, Synonyms: Thymine-2-deoxyriboside, Deoxythymidine, DT, DTHYD;1-(2-Deoxy-B-D-ribofuranosyl)-5-methyluracil, size: 25G
ADENOSINE-5'-DIPHOSP 1.00 GM - 0210005601, 1 g
ADENOSINE-5'-DIPHOSP 5.00 GM - 0210005605, 5 g
N-ACETYL-L-CYSTEINE 25.00 GM - 0210009825, 25 g
N-ACETYL-L-CYSTEINE 50.00 GM - 0210009850, 50 g
N-ACETYL-L-CYSTEINE 100.00 GM - 0210009880, 100 g
N-ACETYL-L-CYSTEINE 500.00 GM - 0210009890, 500 g
N-ACETYL-L-CYSTEINE 1000 GM - 0210009891, 1 kg
N-ACETYL-MANNOSAMINE 1.00 GM - 0210010901, 1 g
N-ACETYL-MANNOSAMINE 5.00 GM - 0210010905, 5 g
N-ACETYL-MANNOSAMINE 0.25 GM - 02100109.2, 250 mg
N-Acetyl-DL-Tryptophan. Acetyltryptophan. CAS RN 87-32-1. Formula Weight: 246.3. Melting Point: 204-206[degree]C. Crystalline, 99% min. 25g
N-Acetyl-DL-Tryptophan. Acetyltryptophan. CAS RN 87-32-1. Formula Weight: 246.3. Melting Point: 204-206[degree]C. Crystalline, 99% min. 100g
L-ALANINE--N/H 0.025 KG 0.03KG - 02100287.3, 25 g
L-ARGININE FREE BAS 100.00 GM - 0210073680, 100 g
L-ARGININE FREE BAS 500.00 GM - 0210073690, 500 g
L-ARGININE FREE BAS 1000 GM - 0210073691, 1 kg
L-ARGININE MONOHYDRO 500.00 GM - 0210074390, 500 g
L-ARGININE MONOHYDRO 1000 GM - 0210074391, 1 kg
L-ASPARAGINE ANHYDR 25.00 GM - 0210079425, 25 g
L-ASPARAGINE ANHYDR 100.00 GM - 0210079480, 100 g
L-ASPARAGINE ANHYDR 500.00 GM - 0210079490, 500 g
DL-ASPARTIC ACID--N/ 500.00 GM - 0210080390, 500 g
DL-ASPARTIC ACID--N/ 1000 GM - 0210080391, 1 kg
B-ALANINE 1.00 KG - 0210092901, 1 kg
B-ALANINE 0.50 KG - 02100929.5, 500 g
PHOSPHATIDYL-L-SERIN 10.00 MG - 0210096910, 10 mg
PHOSPHATIDYL-L-SERIN 50.00 MG - 0210096950, 50 mg
L-CYSTEINE FREE BAS 100.00 GM - 0210144480, 100 g
L-CYSTEINE FREE BAS 500.00 GM - 0210144490, 500 g
L-CYSTEINE HYDROCHLO 1.00 KG - 0210144601, 1 kg
L-CYSTEINE HYDROCHLO 0.10 KG - 02101446.1, 100 g
L-CYSTEINE HYDROCHLO 0.025 KG - 02101446.3, 25 g
L-CYSTEINE HYDROCHLO 0.50 KG - 02101446.5, 500 g
DL-CYSTINE DIHYDROCH 5.00 GM - 0210145205, 5 g
L-CYSTINE--N/H 25.00 GM - 0210145425, 25 g
L-CYSTINE--N/H 100.00 GM - 0210145480, 100 g
L-CYSTINE--N/H 500.00 GM - 0210145490, 500 g
L-CYSTINE--N/H 1000 GM - 0210145491, 1 kg
L-GLUTAMIC ACID--N/H 1.00 KG - 0210179301, 1 kg
L-GLUTAMIC ACID MONO 100.00 GM - 0210180080, 100 g
L-GLUTAMIC ACID MONO 1000 GM - 0210180091, 1 kg
L-(+)-Glutamine. L-2-Aminoglutaramic Acid. CAS RN 56-85-9. Formula Weight: 146.15. Crystalline, 99-100% Pure.
0.2% free ammonia and 0.1% residue on ignition. 5g.
L-(+)-Glutamine. L-2-Aminoglutaramic Acid. CAS RN 56-85-9. Formula Weight: 146.15. Crystalline, 99-100% Pure.
0.2% free ammonia and 0.1% residue on ignition. 100g.
L-(+)-Glutamine. L-2-Aminoglutaramic Acid. CAS RN 56-85-9. Formula Weight: 146.15. Crystalline, 99-100% Pure.
0.2% free ammonia and 0.1% residue on ignition. 250g.
L-(+)-Glutamine. L-2-Aminoglutaramic Acid. CAS RN 56-85-9. Formula Weight: 146.15. Crystalline, 99-100% Pure.
0.2% free ammonia and 0.1% residue on ignition. 500g.
Glycylglycine (Gly-Gly) - 0210185610, 10 g
Glycylglycine (Gly-Gly) - 0210185680, 100 g
L-HISTIDINE FREE BAS 100.00 GM - 0210195480, 100 g
L-HISTIDINE FREE BAS 500.00 GM - 0210195490, 500 g
L-HISTIDINE FREE BAS 1000 GM - 0210195491, 1 kg
L-HISTIDINE HYDROCHL 25.00 GM - 0210195725, 25 g
L-HISTIDINE HYDROCHL 100.00 GM - 0210195780, 100 g
L-HISTIDINE HYDROCHL 500.00 GM - 0210195790, 500 g
L-HISTIDINE HYDROCHL 1000GM - 0210195791, 1 kg
L-LEUCINE (N/H) 1.00 KG - 0210215801, 1 kg
L-Leu-L-Ala - 0210216701, 1 g
O-PHTHALALDEHYDE--N/ 1.00 GM - 0210264801, 1 g
O-PHTHALALDEHYDE--N/ 5.00 GM - 0210264805, 5 g
Poly-L-lysine hydrobromide - 0210269180, 100 mg
Poly-L-lysine hydrobromide - 0210269190, 500 mg
POLY-D-LYSINE HYDROB 10.00 MG - 0210269410, 10 mg
POLY-D-LYSINE HYDROB 50.00 MG - 0210269450, 50 mg
POLY-D-LYSINE HYDROB 100.00 MG - 0210269480, 100 mg
POLY-D-LYSINE HYDROB 500.00 MG - 0210269490, 500 mg
POLY-D-LYSINE HYDROB 1000 MG - 0210269491, 1 g
L-PROLINE 25.00 GM - 0210273025, 25 g
L-PROLINE 100.00 GM - 0210273080, 100 g
L-PROLINE 1000 GM - 0210273091, 1 kg
DL-SERINE 25.00 GM - 0210286825, 25 g
DL-SERINE 100.00 GM - 0210286880, 100 g
DL-SERINE 1000 GM - 0210286891, 1 kg
Category
Ambulatory Equipment
Apparel
Appliances (Durable Goods)
Body Pressure Relief and Positioning
Clinical Laboratory
Diagnostic Instruments and Supplies
Drainage and Suction
Furnishings
Gloves
Housekeeping
Implants
Incontinence
Indicators and Signage
Instruments
IV Therapy
Needles and Syringes
Nurse's Station and Office Supplies
Nutritionals and Feeding Supplies
Orthopedic
Ostomy
other
Personal Hygiene
Pharmaceuticals
Physical Therapy
Respiratory
Services
Sterilization
Textiles
Training and Education
Urological
Utensils
Ventilators
Wound Care
Wound Closure
Prev
8
9
10
11
12
Next